Literature DB >> 33486430

Residue-based pharmacophore approaches to study protein-protein interactions.

Rojan Shrestha1, Jorge Eduardo Fajardo1, Andras Fiser2.   

Abstract

This review focuses on pharmacophore approaches in researching protein interfaces that bind protein ligands. Pharmacophore descriptions of binding interfaces that employ molecular dynamics simulation can account for effects of solvation and conformational flexibility. In addition, these calculations provide an approximation to entropic considerations and as such, a better approximation of the free energy of binding. Residue-based pharmacophore approaches can facilitate a variety of drug discovery tasks such as the identification of receptor-ligand partners, identifying their binding poses, designing protein interfaces for selectivity, or defining a reduced mutational combinatorial exploration for subsequent experimental engineering techniques by orders of magnitudes.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33486430      PMCID: PMC8439153          DOI: 10.1016/j.sbi.2020.12.016

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  57 in total

Review 1.  Prediction of protein-protein interactions by docking methods.

Authors:  Graham R Smith; Michael J E Sternberg
Journal:  Curr Opin Struct Biol       Date:  2002-02       Impact factor: 6.809

Review 2.  Sequence, structure, function, immunity: structural genomics of costimulation.

Authors:  Kausik Chattopadhyay; Eszter Lazar-Molnar; Qingrong Yan; Rotem Rubinstein; Chenyang Zhan; Vladimir Vigdorovich; Udupi A Ramagopal; Jeffrey Bonanno; Stanley G Nathenson; Steven C Almo
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

3.  Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma.

Authors:  J J Baldwin; G S Ponticello; P S Anderson; M E Christy; M A Murcko; W C Randall; H Schwam; M F Sugrue; J P Springer; P Gautheron
Journal:  J Med Chem       Date:  1989-12       Impact factor: 7.446

4.  Common Hits Approach: Combining Pharmacophore Modeling and Molecular Dynamics Simulations.

Authors:  Marcus Wieder; Arthur Garon; Ugo Perricone; Stefan Boresch; Thomas Seidel; Anna Maria Almerico; Thierry Langer
Journal:  J Chem Inf Model       Date:  2017-01-20       Impact factor: 4.956

5.  Trends in structural coverage of the protein universe and the impact of the Protein Structure Initiative.

Authors:  Kamil Khafizov; Carlos Madrid-Aliste; Steven C Almo; Andras Fiser
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

6.  Computer-Aided Drug Design Methods.

Authors:  Wenbo Yu; Alexander D MacKerell
Journal:  Methods Mol Biol       Date:  2017

7.  Analysis of protein binding sites by computational solvent mapping.

Authors:  David R Hall; Dima Kozakov; Sandor Vajda
Journal:  Methods Mol Biol       Date:  2012

8.  ProtLID, a Residue-Based Pharmacophore Approach to Identify Cognate Protein Ligands in the Immunoglobulin Superfamily.

Authors:  Eng-Hui Yap; Andras Fiser
Journal:  Structure       Date:  2016-11-23       Impact factor: 5.006

9.  Dynamics based pharmacophore models for screening potential inhibitors of mycobacterial cyclopropane synthase.

Authors:  Chinmayee Choudhury; U Deva Priyakumar; G Narahari Sastry
Journal:  J Chem Inf Model       Date:  2015-03-16       Impact factor: 4.956

10.  Protein-protein binding supersites.

Authors:  Raji Viswanathan; Eduardo Fajardo; Gabriel Steinberg; Matthew Haller; Andras Fiser
Journal:  PLoS Comput Biol       Date:  2019-01-07       Impact factor: 4.779

View more
  1 in total

1.  Allosteric regulation of binding specificity of HVEM for CD160 and BTLA ligands upon G89F mutation.

Authors:  Rojan Shrestha; Sarah Garrett-Thomson; Weifeng Liu; Steven C Almo; Andras Fiser
Journal:  Curr Res Struct Biol       Date:  2021-11-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.